Search

everythinglearnresearchcommunity

for

Search:↓

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

CS12192 effectively treats alopecia areata with better safety than current options.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib treatment is used for teenagers with alopecia areata.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Upadacitinib effectively treats pyoderma gangrenosum.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Imuvert can prevent some chemotherapy-induced hair loss.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Cetuximab can cause excessive eyelash growth.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.